Curated News
By: NewsRamp Editorial Staff
October 29, 2024
Association for Treatment of Neuroplastic Symptoms (ATNS) Announces Rebranding as Symptomatic
TLDR
- ATNS leads in sharing new science for treating neuroplastic symptoms, giving an edge in understanding and treating chronic pain.
- ATNS rebrands to focus on neuroplastic symptoms, offering evidence-based approach to treating chronic pain and illness.
- ATNS aims to empower patients and practitioners with knowledge for effective, compassionate care, transforming lives through understanding and treatment of neuroplastic symptoms.
- Learn more about the brain's ability to adapt, change, and heal, and how it affects chronic pain and illness at Symptomatic.Me.
Impact - Why it Matters
This news matters because it highlights a shift in the medical community's approach to chronic pain and illness, offering hope for more effective, compassionate care for those who need it most. The rebranding signifies a commitment to empowering people to understand and overcome neuroplastic symptoms with the newest science, potentially leading to real, sustainable healing options for millions worldwide.
Summary
The Psychophysiologic Disorders Association (PPDA) has rebranded as the Association for Treatment of Neuroplastic Symptoms (ATNS) under the new brand of Symptomatic. This transformation reflects a renewed focus on treating chronic pain and illness with an evidence-based approach, emphasizing neuroplasticity. The organization's mission remains educating practitioners and patients about neuroplastic symptoms and the brain's ability to adapt, change, and heal.
Source Statement
This curated news summary relied on content disributed by 24-7 Press Release. Read the original source here, Association for Treatment of Neuroplastic Symptoms (ATNS) Announces Rebranding as Symptomatic
